GLP-1 and CT/MRI Contrast: Fasting Rules (2026)

If you take Ozempic, Wegovy, Mounjaro, Zepbound or another GLP-1 and you have a CT or MRI with contrast coming up, you may have read scary headlines about holding the drug before procedures and wondered whether the same applies to imaging. The honest, evidence-based answer for most scans is reassuring: a routine, awake CT or MRI is not a sedated procedure, so the aspiration concern that drives the GLP-1 “hold” debate largely does not apply. The real nuance is narrower and twofold. First, a minority of imaging is done under sedation or general anesthesia (some MRIs, most pediatric scans, claustrophobic patients) — and there, the same delayed-gastric-emptying aspiration question that applies to endoscopy and surgery applies to you. Second, GLP-1 drugs slow how fast the stomach empties, which can leave retained gastric contents that may affect oral-contrast studies (oral-contrast CT, MR enterography). This article separates those situations from the much larger group of routine scans where you almost certainly do not need to do anything. For the broader procedure picture, see holding a GLP-1 before surgery and anesthesia and GLP-1s and colonoscopy prep.

The honest summary

• For most CT/MRI, no hold is needed. Routine contrast scans are done awake, with no sedation. Aspiration — the entire reason the GLP-1 “hold” debate exists — is a sedation/anesthesia concern, not an awake-imaging concern.
• IV-contrast fasting rules are already loosening anyway. Major guidelines no longer require fasting before intravenous iodinated contrast for awake exams; abolishing the fasting instruction did not increase acute reactions (Tsushima 2020^[8]; Choi 2023^[9]).
• The nuance #1: sedated imaging. If your CT or MRI is done under sedation or general anesthesia, the delayed-emptying aspiration question that applies to surgery and endoscopy applies to you too (Kindel 2024^[3]; Hiramoto 2024^[10]).
• The nuance #2: oral contrast. GLP-1s leave more food and fluid in the stomach (about 4.5× the odds of retained gastric contents at endoscopy in pooled data), which can muddy oral-contrast filling and even mimic pathology on abdominal CT (Baig 2025^[1]; Silveira 2023^[5]).
• Delayed emptying is measurable but modest. A meta-analysis quantified the gastric-emptying delay from GLP-1s as real but variable, and concluded standard fasting may be insufficient mainly in higher-risk, sedated contexts (Hiramoto 2024^[10]).
• Bottom line: ask whether your scan is sedated and whether it uses oral contrast. If neither, you almost certainly continue as normal. If either, coordinate with the imaging center and your prescriber — don't self-discontinue.

Why GLP-1s came up in the imaging conversation at all

GLP-1 receptor agonists slow gastric emptying — that delayed emptying is part of how they curb appetite. The downside surfaced in anesthesia and endoscopy: a stomach that isn't fully empty after standard fasting raises a theoretical risk of regurgitating and aspirating contents into the lungs under sedation. The first hard signal came from Silveira 2023^[5], a retrospective study of 404 patients having upper endoscopy: those who'd taken semaglutide within 30 days had retained gastric contents 24.2% of the time versus 5.1% of non-users (adjusted odds ratio about 5.2). A prospective gastric-ultrasound study in volunteers found the same direction of effect (Sherwin 2023^[6]), and a pooled analysis of 23 studies and 262,018 patients put the odds of retained gastric contents at about 4.5× — though, importantly, without a significant increase in aspiration pneumonia (Baig 2025^[1]).

That body of evidence is about sedated procedures. The leap that worries patients is whether it carries over to imaging. It does — but only partway, and only to specific scenarios. The key distinction is whether your scan involves sedation, and whether it relies on oral contrast.

Routine (non-sedated) CT and MRI: the hold debate usually doesn't apply

For a standard awake CT or MRI — with or without intravenous contrast — the GLP-1 “hold” debate generally does not apply. There is no airway-management step, no sedation, and therefore no aspiration scenario for retained gastric contents to feed into. On top of that, the broader trend in radiology has actually been away from strict fasting for contrast at all.

For intravenous iodinated contrast (the dye injected for contrast-enhanced CT and CT angiography), modern guidance no longer mandates fasting. A large study found that abolishing the instruction to fast before contrast-enhanced CT did not increase the incidence of acute adverse reactions (Tsushima 2020^[8]), and a guideline review concluded that routine fasting before intravascular iodinated contrast is unnecessary for most patients (Choi 2023^[9]). The historical reason people fasted — fear of contrast-induced nausea and vomiting causing aspiration — turned out not to be supported by outcome data in awake patients. Because GLP-1 concerns are downstream of that same aspiration worry, the loosening of IV-contrast fasting rules further weakens the case for any special GLP-1 handling in awake imaging.

Nuance #1: sedated imaging — here the surgery/endoscopy logic applies

A minority of imaging is performed under sedation or general anesthesia: some MRIs in adults who can't tolerate the scanner (claustrophobia, movement disorders, pain), procedural/interventional radiology, and the great majority of pediatric CT/MRI, where young children are routinely sedated to hold still. In these cases, your airway reflexes are blunted, and the exact same delayed-gastric-emptying aspiration question that applies to surgery and endoscopy applies to imaging.

The 2024 multisociety perioperative guidance — written jointly by anesthesiology, gastroenterology and bariatric-surgery groups — is explicitly about “the perioperative period” and procedural sedation, not awake imaging, but its principles port directly to sedated scans (Kindel 2024^[3]). It favors shared decision-making that balances the need for the drug against individual aspiration risk; for patients where delayed emptying is a concern, it suggests a clear-liquid diet for at least 24 hours before the sedated procedure (in addition to or instead of holding the drug), point-of-care gastric ultrasound on the day, or treating the patient as a “full stomach” with a rapid-sequence technique. A meta-analysis quantifying the emptying delay reached a similar practical conclusion: the delay is real and standard fasting may be insufficient in higher-risk, sedated contexts, so periprocedural management should be individualized (Hiramoto 2024^[10]).

The original June 2023 American Society of Anesthesiologists (ASA) consensus — to skip daily-dosed GLP-1s on the day and hold weekly-dosed agents (Ozempic, Wegovy, Mounjaro, Zepbound) roughly a week before — was framed around “elective procedures,” which a sedated scan can fall under. So if your imaging is sedated, expect your anesthesia/sedation team to ask the same questions they'd ask before any sedated procedure, and to apply your facility's GLP-1 protocol. This is not a reason to skip a needed scan; it's a reason to coordinate the plan in advance.

Nuance #2: oral contrast — a quality (and incidental-finding) issue more than a safety one

Some CT and MRI studies use oral contrast — you drink a barium or iodinated solution (or, for MR enterography, a large volume of an osmotic agent) so the stomach and bowel light up or distend on the images. GLP-1-slowed gastric emptying intersects with these studies in two ways, neither of which is primarily about aspiration in an awake patient.

First, image quality and timing. Oral-contrast protocols assume the contrast moves through the stomach into the small bowel on a predictable schedule. If your stomach empties slowly, contrast (and any retained food) may sit in the stomach longer, potentially leaving the distal bowel under-opacified at the scheduled scan time, or leaving a stomach full of mixed food and contrast that's harder to interpret. The same retained-content phenomenon documented at endoscopy (Baig 2025^[1]; Silveira 2023^[5]) is what underlies this — only here the consequence is a potentially suboptimal study rather than an airway risk.

Second, incidental findings. A stomach unexpectedly full of retained food on an abdominal CT can be mistaken for gastric outlet obstruction, a mass, or a motility disorder if the radiologist doesn't know you take a GLP-1. Telling the imaging team you're on the drug helps them interpret a full stomach correctly as a known pharmacologic effect rather than a worrying new finding. This is a recognized interpretive pitfall as GLP-1 use becomes common.

Notably, the “fuller stomach” effect isn't uniform: in pooled endoscopy data, doing an upper endoscopy together with a colonoscopy on the same day was associated with lower odds of retained contents, because colonoscopy requires a clear-liquid bowel prep that empties the stomach more thoroughly (Baig 2025^[1]; Ukwade 2025^[4]). The practical analog for oral-contrast imaging: a thorough clear-liquid period beforehand helps, and your center may extend it if you're on a GLP-1.

What this means for you — the practical upshot

• Ask two questions when you book or check in: (1) Will I be sedated or under anesthesia for this scan? (2) Does this study use oral contrast? If the answer to both is no, you almost certainly continue your GLP-1 as usual and follow the standard prep sheet.
• If the scan is sedated, tell the sedation/anesthesia team which GLP-1 you take, your dose, and when you last took it — and follow your facility's perioperative GLP-1 protocol (which may involve a clear-liquid day, a held dose, or gastric ultrasound). Don't self-discontinue; see the surgery/anesthesia guidance.
• If the scan uses oral contrast, tell the imaging center you're on a GLP-1 so they can interpret a full stomach correctly and, if needed, adjust timing or extend clear liquids for better opacification.
• You generally do NOT need to stop your GLP-1 for a routine awake CT or MRI — including most contrast-enhanced (IV-dye) scans, since modern guidelines have moved away from requiring fasting for IV contrast at all (Tsushima 2020^[8]; Choi 2023^[9]).
• Flag ongoing GI symptoms. Nausea, vomiting, bloating or feeling full predict more retained stomach contents (Silveira 2023^[5]). If you have them near a sedated or oral-contrast scan, say so — it may change the plan.
• Follow YOUR facility's written instructions. Imaging-center protocols differ; the prep sheet you're given is the one that counts.

Bottom line

For the great majority of CT and MRI scans — done awake, often with intravenous contrast — being on a GLP-1 changes nothing, and you typically do not need to hold the drug. The aspiration concern that drives the GLP-1 “hold” debate is a sedation problem, and modern guidelines have even relaxed fasting for awake IV contrast (Tsushima 2020^[8]; Choi 2023^[9]). The real, narrower nuances are two: sedated imaging, where the same delayed-emptying logic as surgery and endoscopy applies (Kindel 2024^[3]; Hiramoto 2024^[10]), and oral-contrast studies, where slowed emptying can muddy opacification or make a full stomach look like pathology (Baig 2025^[1]; Silveira 2023^[5]). The single most useful thing you can do is ask whether your scan is sedated and whether it uses oral contrast — and, if either is true, coordinate with the imaging center and your prescriber rather than deciding alone.

This article is educational and is not medical advice. Every claim above is sourced to a peer-reviewed study, society clinical practice update, or guideline indexed in PubMed and verified against the live PubMed database before publication. Coordinate your own pre-imaging plan with your prescriber and imaging center.